Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing loratadine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine adverse reaction |
Causative agent (attribute) |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Allergy to loratadine (finding) |
Causative agent (attribute) |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine+pseudoephedrine sulfate 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 10mg/10mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 0.01g tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Product containing loratadine and pseudoephedrine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine orally disintegrating 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 1 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 5 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Allergy to loratadine (finding) |
Causative agent (attribute) |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Product containing loratadine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
2 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loratadine (substance) |
Inferred relationship |
Some |
|
Loratadine 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
2 |
Product containing loratadine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
2 |
Loratadine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
2 |
Loratadine 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
2 |
Loratadine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
2 |
Loratadine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 5 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 5 mg chewable tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 1 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine 1 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Loratadine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ambroxol hydrochloride 60 milligram and loratadine 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ambroxol hydrochloride 60 milligram and loratadine 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Ambroxol- and loratadine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Product containing ambroxol and loratadine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Ambroxol and loratadine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |
Ambroxol and loratadine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Loratadine (substance) |
Inferred relationship |
Some |
1 |